The best why that I have put inhibitors in is by using the sketcher program
in CCP4.  Its a little unwieldy at first but if you get the hang of it, it
provides pdb's and library files that can be directly inputed into refmac
and Coot.  The Coot ligand find function does a pretty good job of initially
placing inhibitors in density.

The only thing to be careful of is that sketcher tends to label hydrogens in
a problematic way for large ligands.  It labels the hydrogen based on the
carbon number that it is attached too.  Problems tend to occur if the
hydrogens get three digit labels.  Refmac won't necessarily recognize these
causing problems with the cif file.  If this problem occurs re-label the
hydrogens to two digit numbers.  Unless your using a ligand that requires
more than 100 hydrogens.  Then you will have to build it a different way.

Scott


On Wed, Oct 1, 2008 at 3:38 PM, Anastassis Perrakis <[EMAIL PROTECTED]>wrote:

> On Sep 30, 2008, at 9:56, Anshul Awasthi wrote:
>
>  Hi all the crystallographers,
>>
>> I am trying to solve a structure of a protein with some inhibitor. I want
>> to
>> know how I can put in my inhibitor in the density map of the data i got. I
>> can see some density in the active site where the  inhibitor should be. I
>> generated the topoly file of the inhibitor (in both pdba nd refmac5 top
>> formats) from the Dundee PRODRG server. Now do i need to incorporate the
>> structure of the inhibitor in ccp4 or can i do in coot?? I am not sure of
>> how to do it.
>>
>
> As one of many alternatives you can use "ARP/wARP Ligand Fit"  from the
> CCP4I
> (provided you downloaded and installed the current version of ARP/wARP)
> and then input your protein structure, the observed data, and the PDB of
> your ligand.
>
> The script will calculate the mFo-DFc map, find the most likely site for
> the ligand,
> and then fir the ligand there, and refine it in real space.
>
> Tassos
>
>
>>
>> ANy sugegstion will be very valuable for me.
>>
>
>


-- 
Scott D. Pegan, Ph.D.
Senior Research Specialist
Center for Pharmaceutical
Biotechnology
University of Illinois at Chicago

Reply via email to